For the year ending 2025-12-31, CL had $192M increase in cash & cash equivalents over the period. $3,634M in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income including noncontrolling interests | 2,261 | 3,049 | 2,455 | 1,967 |
| Depreciation and amortization | 630 | 605 | 567 | 545 |
| Erisa litigation matter | 65 | 0 | 267 | - |
| Restructuring and termination benefits, net of cash | -7 | 51 | -23 | 49 |
| Stock-based compensation expense | 155 | 135 | 122 | 125 |
| Gain on the sale of land | - | 0 | 0 | 47 |
| Goodwill and intangible assets impairment charges | 919 | 0 | 0 | 721 |
| Loss on early extinguishment of debt | - | - | 0 | 0 |
| Deferred income taxes | -109 | -77 | -98 | -78 |
| Receivables | 16 | 56 | 37 | 227 |
| Inventories | -109 | 100 | -194 | 333 |
| Accounts payable and other working capital | 251 | - | - | - |
| Accounts payable and other accruals | - | 516 | 309 | -115 |
| Other non-current assets | -35 | - | - | - |
| Other non-current assets and liabilities | - | 16 | 11 | 51 |
| Other non-current liabilities | -95 | - | - | - |
| Net cash provided by operations | 4,198 | 4,107 | 3,745 | 2,556 |
| Capital expenditures | 564 | 561 | 705 | 696 |
| Purchases of marketable securities and investments | 698 | 574 | 506 | 470 |
| Proceeds from sale of marketable securities and investments | 752 | 564 | 502 | 322 |
| Payment for acquisitions, net of cash acquired | 293 | 0 | 0 | 809 |
| Proceeds from the sale of land | - | 0 | 0 | 47 |
| Other investing activities | 14 | -37 | 33 | -5 |
| Net cash used in investing activities | -817 | -534 | -742 | -1,601 |
| Short-term borrowing (repayment) less than 90 days, net | -989 | 93 | -906 | 540 |
| Principal payments on debt | 655 | 503 | 903 | 406 |
| Proceeds from issuance of debt | 1,188 | 2 | 1,495 | 1,513 |
| Dividends paid | 1,823 | 1,789 | 1,749 | 1,691 |
| Purchases of treasury shares | 1,210 | 1,739 | 1,128 | 1,308 |
| Proceeds from exercise of stock options | 101 | 638 | 380 | 418 |
| Purchases of non-controlling interests in subsidiaries | - | - | - | 0 |
| Other financing activities | 132 | -91 | 18 | -18 |
| Net cash used in financing activities | -3,256 | -3,389 | -2,793 | -952 |
| Effect of exchange rate changes on cash and cash equivalents | 67 | -54 | -19 | -60 |
| Net increase (decrease) in cash and cash equivalents | 192 | 130 | 191 | -57 |
| Cash and cash equivalents at beginning of year | 1,096 | 966 | 775 | 832 |
| Cash and cash equivalents at end of year | 1,288 | 1,096 | 966 | 775 |
COLGATE PALMOLIVE CO (CL)
COLGATE PALMOLIVE CO (CL)